These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 23592747

  • 1. Epitope recognition in HLA-DR3 transgenic mice immunized to TSH-R protein or peptides.
    Inaba H, Moise L, Martin W, De Groot AS, Desrosiers J, Tassone R, Buchman G, Akamizu T, De Groot LJ.
    Endocrinology; 2013 Jun; 154(6):2234-43. PubMed ID: 23592747
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of glutamic or aspartic acid in position four of the epitope binding motif and thyrotropin receptor-extracellular domain epitope selection in Graves' disease.
    Inaba H, Martin W, Ardito M, De Groot AS, De Groot LJ.
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2909-16. PubMed ID: 20392871
    [Abstract] [Full Text] [Related]

  • 4. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
    Pichurin P, Pham N, David CS, Rapoport B, McLachlan SM.
    Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
    Li CW, Osman R, Menconi F, Concepcion E, Tomer Y.
    J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336
    [Abstract] [Full Text] [Related]

  • 7. Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition.
    Ueda Y, Sugawa H, Akamizu T, Okuda J, Ueda M, Kosugi S, Ohta C, Kihou Y, Mori T.
    Eur J Endocrinol; 1995 Jan; 132(1):62-8. PubMed ID: 7531576
    [Abstract] [Full Text] [Related]

  • 8. Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b.
    Pichurin P, Chen CR, Pichurina O, David C, Rapoport B, McLachlan SM.
    Thyroid; 2003 Oct; 13(10):911-7. PubMed ID: 14611699
    [Abstract] [Full Text] [Related]

  • 9. Relationship between thyroid peroxidase T cell epitope restriction and antibody recognition of the autoantibody immunodominant region in human leukocyte antigen DR3 transgenic mice.
    Guo J, McLachlan SM, Pichurin PN, Chen CR, Pham N, Aliesky HA, David CS, Rapoport B.
    Endocrinology; 2005 Nov; 146(11):4961-7. PubMed ID: 16081633
    [Abstract] [Full Text] [Related]

  • 10. Acetylcholine receptor peptide recognition in HLA DR3-transgenic mice: in vivo responses correlate with MHC-peptide binding.
    Raju R, Spack EG, David CS.
    J Immunol; 2001 Jul 15; 167(2):1118-24. PubMed ID: 11441124
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD.
    Deshmukh US, Sim DL, Dai C, Kannapell CJ, Gaskin F, Rajagopalan G, David CS, Fu SM.
    J Autoimmun; 2011 Nov 15; 37(3):254-62. PubMed ID: 21868195
    [Abstract] [Full Text] [Related]

  • 13. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
    Inaba H, Martin W, De Groot AS, Qin S, De Groot LJ.
    J Clin Endocrinol Metab; 2006 Jun 15; 91(6):2286-94. PubMed ID: 16595602
    [Abstract] [Full Text] [Related]

  • 14. Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application: evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule.
    Sugawa H, Akamizu T, Kosugi S, Ueda Y, Ohta C, Okuda J, Mori T.
    Eur J Endocrinol; 1995 Sep 15; 133(3):283-93. PubMed ID: 7581943
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic Mice.
    Jansson L, Vrolix K, Jahraus A, Martin KF, Wraith DC.
    Endocrinology; 2018 Sep 01; 159(9):3446-3457. PubMed ID: 30099489
    [Abstract] [Full Text] [Related]

  • 16. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
    Wu X, Tuzun E, Saini SS, Wang J, Li J, Aguilera-Aguirre L, Huda R, Christadoss P.
    Immunol Lett; 2015 Dec 01; 168(2):306-12. PubMed ID: 26493475
    [Abstract] [Full Text] [Related]

  • 17. Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice.
    Flynn JC, Gardas A, Wan Q, Gora M, Alsharabi G, Wei WZ, Giraldo AA, David CS, Kong YM, Banga JP.
    Clin Exp Immunol; 2004 Sep 01; 137(3):503-12. PubMed ID: 15320899
    [Abstract] [Full Text] [Related]

  • 18. Cepharanthine Blocks Presentation of Thyroid and Islet Peptides in a Novel Humanized Autoimmune Diabetes and Thyroiditis Mouse Model.
    Li CW, Osman R, Menconi F, Faustino LC, Kim K, Clarke OB, Hou H, Tomer Y.
    Front Immunol; 2021 Sep 01; 12():796552. PubMed ID: 34987519
    [Abstract] [Full Text] [Related]

  • 19. Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy.
    Burch HB, Sellitti D, Barnes SG, Nagy EV, Bahn RS, Burman KD.
    J Clin Endocrinol Metab; 1994 Jun 01; 78(6):1384-91. PubMed ID: 8200941
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.